Lena Hagman
Chief Operating Officer bij XVIVO PERFUSION AB
Vermogen: 51 437 $ op 31-03-2024
Profiel
Momenteel is Lena Hagman Executive Vice President-Quality Regulatory bij Getinge AB. Voorheen bekleedde mevrouw Hagman de functie van Operations Director bij Neoventa Medical AB.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
XVIVO PERFUSION AB
0.01% | 31-12-2022 | 2 000 ( 0.01% ) | 51 437 $ | 31-03-2024 |
Actieve functies van Lena Hagman
Bedrijven | Functie | Begin |
---|---|---|
XVIVO PERFUSION AB | Chief Operating Officer | 01-12-2022 |
Eerdere bekende functies van Lena Hagman
Bedrijven | Functie | Einde |
---|---|---|
GETINGE AB | Compliance Officer | 01-10-2020 |
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Chief Operating Officer | - |
Opleiding van Lena Hagman
Chalmers University of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GETINGE AB | Health Technology |
XVIVO PERFUSION AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Health Technology |